Tochigi

The trials here

What the 12 trials at this site are about, from their registry records.

Conditions

• Childhood cancers5 trials
• Asthma2 trials
• Chronic kidney disease2 trials
• Heart failure2 trials
• Liver and biliary tract cancer2 trials
• Coronary artery disease1 trial
• Lung cancer1 trial
• Lupus (SLE)1 trial
• Pancreatic cancer1 trial

Status

• Completed10 trials
• Active, not recruiting2 trials

Lead sponsor

• AstraZeneca12 trials

Running trials

• Active, not recruiting

  TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)

  NCT05729711· AstraZeneca· Source

• Active, not recruiting

  SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)

  NCT05141201· AstraZeneca· Source

Closed trials

• Completed

  A Study to Evaluate the Association of Biliary Complications and Treatment Duration in Unresectable BTC Patients

  NCT07101874· AstraZeneca· Source

• Completed

  Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

  NCT05835778· AstraZeneca· Source

• Completed

  Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

  NCT05826366· AstraZeneca· Source

• Completed

  LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)

  NCT05677308· AstraZeneca· Source

• Completed

  An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure

  NCT05297409· AstraZeneca· Source

• Completed

  Forxiga CKD Japan Post-Marketing Surveillance (PMS)

  NCT05306210· AstraZeneca· Source

• Completed

  LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)

  NCT04889404· AstraZeneca· Source

• Completed

  Forxiga HF General Drug Use-Results Study

  NCT04865406· AstraZeneca· Source

• Completed

  FASENRA SCEI for Long-term Use

  NCT03588546· AstraZeneca· Source

• Completed

  Brilinta Clinical Experience Investigation

  NCT03212287· AstraZeneca· Source